BrightPath Biotherapeutics Co., Ltd.
iPS-NKTはiPS細胞から再分化誘導したNKT細胞を用いた新規他家がん免疫細胞医薬です 多面的な抗腫瘍効果を持つものの血中にはわずかしか存在しないため、細胞医薬へは適用困難と考えられていたNKT細胞が、iPS細胞技術によって、健常人ドナーの血液由来のマスターiPSセルバンクから大量かつ均質に製造可能になりました もともとがん細胞傷害能をもつ免疫細胞に、遺伝子改変を加え、がん細胞傷害性、持続性などの機能を高めたり、体内動態を改善させたりすることによって、がん治療効果をさらに高めたものです
Basic Information
- Category: business
- Website: https://www.brightpathbio.com/
Documented Facts
- Inception (Wikidata): 2003-05-08 (Source 2: Wikidata Q27017009, revision 2534895870)
- Country (Wikidata; date unspecified): Japan (Source 2: Wikidata Q27017009, revision 2534895870; Source 3: Wikidata label: Q17, revision 2555599058)
- Official website (Wikidata; date unspecified): https://www.brightpathbio.com/ (Source 2: Wikidata Q27017009, revision 2534895870)
Evidence and Sources
- BrightPath Biotherapeutics Co., Ltd. — Official Site (official)
- Wikidata Q27017009, revision 2534895870 (knowledge-base)
- Wikidata label: Q17, revision 2555599058 (knowledge-base)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about BrightPath Biotherapeutics Co., Ltd..
- Canonical profile: https://brandsource.ai/brands/brightpath-biotherapeutics-co-ltd
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/brightpath-biotherapeutics-co-ltd/json-ld
- Citation profile API: https://brandsource.ai/api/brands/brightpath-biotherapeutics-co-ltd/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (73/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
BrightPath Biotherapeutics Co., Ltd. is listed in business on BrandSource.AI.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 supporting sources linked.
- 3 structured facts available for extraction.
Known data gaps
- Needs a specific, non-thin summary
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.